BRIEF-Ocuphire Pharma announces acquisition of Opus Genetics-February 2024-www.financetom.com

BRIEF-Ocuphire Pharma announces acquisition of Opus Genetics

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Ocuphire Pharma announces acquisition of Opus Genetics

Oct 22, 2024 2:53 PM

Oct 22 (Reuters) - Ocuphire Pharma Inc ( OCUP ):

* OCUPHIRE PHARMA ANNOUNCES ACQUISITION OF OPUS GENETICS

* OCUPHIRE PHARMA INC ( OCUP ) - PROJECTED CASH RUNWAY EXTENDED INTO

2026

* OCUPHIRE PHARMA INC ( OCUP ) - COMBINED COMPANY TO BE RENAMED OPUS

GENETICS, TRADING AS 'IRD'

* OCUPHIRE PHARMA INC ( OCUP ) - GEORGE MAGRATH TO CONTINUE AS CEO OF

COMBINED COMPANY

* OCUPHIRE PHARMA INC ( OCUP ) - STOCKHOLDERS TO OWN 58%, OPUS

GENETICS

STOCKHOLDERS 42% OF COMBINED CO

* OCUPHIRE PHARMA INC ( OCUP ) - LYNX-2 PHASE 3 TRIAL ON TRACK FOR

TOP-LINE

DATA IN Q1 2025

Source text for Eikon:

Further company coverage:

Previous page： Nukkleus Shares Are On The Rise Today: What's Going On? Next page： D.R. Horton's Fiscal Q1 EPS Likely to Miss Consensus Amid Rising Costs, Wedbush Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nukkleus Shares Are On The Rise Today: What's Going On?

Jan 17, 2025

Nukkleus Inc. ( NUKK ) shares are trading higher Friday potentially on continued momentum after the company announced it had regained compliance with Nasdaq listing requirements. What To Know: The strategic acquisition company received notice that it met the required thresholds, resolving prior compliance issues. To achieve this, Nukkleus ( NUKK ) implemented a 1-for-8 reverse stock split in October,...

D.R. Horton's Fiscal Q1 EPS Likely to Miss Consensus Amid Rising Costs, Wedbush Says

Jan 17, 2025

02:52 PM EST, 01/17/2025 (MT Newswires) -- D.R. Horton ( DHI ) is expected to report fiscal Q1 earnings per share of $2.24, which would fall short of the $2.44 consensus estimate as the company tackles rising land and land development costs, as well as volatile mortgage rates, Wedbush said in an earnings preview Friday. The firm said that the...

Soccer-Manchester United great Law dies at 84

Jan 17, 2025

Jan 17 (Reuters) - Former Manchester United and Scotland forward Denis Law has died at the age of 84, the Premier League club said on Friday. It is with a heavy heart that we tell you our father Denis Law has sadly passed away. He fought a tough battle but finally he is now at peace, a family statement shared...

Goldman CEO gets big pay boost, and $80 million bonus for another five years at helm

Jan 17, 2025

* Waldron widely seen as a successor to Solomon * Solomon's 2024 compensation rose by 26% * Goldman Sachs ( GS ) made $4.11 billion net income in Q4, beating estimates (Recasts first paragraph with bonus, turnaround) By Saeed Azhar NEW YORK, Jan 17 (Reuters) - Goldman Sachs ( GS ) CEO David Solomon was awarded an $80 million stock...